The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor
CBD placebo effects may be sufficient to alter neural responses relevant to its purported anxiolytic and stress-relieving properties. Future work is needed to replicate these results and determine whether CBD expectancy and pharmacology interact to alter neural anxiety reactivity and stress reactivity.
Authors
- Toni C. Spinella (ORCID: https://orcid.org/0000-0002-8956-3488)
- Carl A. Helmick (ORCID: https://orcid.org/0000-0002-1389-968X)
- Robin N Perry (ORCID: https://orcid.org/0000-0003-4528-7853)
- Sherry H. Stewart (ORCID: https://orcid.org/0000-0003-3350-2712)
- Philip G. Tibbo (ORCID: https://orcid.org/0000-0002-2070-6495)
- Sean P. Barrett (ORCID: https://orcid.org/0000-0002-9495-8265)
- Mikeala A Ethier-Gagnon
Institutions
- Dalhousie University (CA)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1177/02698811241287557
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Institutes of Health Research